Biomarkers are essential for improving the diagnosis, prognosis, and treatment of movement disorders. This track will focus on the latest advances in identifying and validating biomarkers, from genetic markers to imaging and fluid-based biomarkers, and discuss their potential applications in clinical trials and daily practice.
Track 19-1: Blood and Genetic Biomarkers for Parkinson’s Disease
Track 19-2: Imaging Biomarkers in Huntington’s Disease
Track 19-3: Biomarkers for Disease Progression and Monitoring
Track 19-4: Biomarkers in Clinical Trials for movement disorders
Track 19-5: Challenges in Biomarker Validation
This track will explore the transformative role of biomarkers in precision medicine and their potential to enhance clinical outcomes for patients with movement disorders.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
